AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA. Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine-

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 )
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Pharmacology 101 Abdelkader Ashour, Ph.D. 7 th Lecture.
BIMM118 Autonomic Nervous System. BIMM118 Autonomic Nervous System Ganglia close to the innervated organs Myelinated axons Ganglia close to the spinal.
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
SYMPATHOMIMETIC DRUGS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Joseph De Soto MD, PhD, FAIC. Overview The adrenergic antagonist bind adrenoreceptors either reversibly or irreversibly preventing or reducing activation.
Adrenoceptor Blockers
Drugs Affecting the Sympathetic Nervous System
ADRENERGIC ANTAGONITS
Alpha Adrenergic receptor blockers
Adrenergic antagonist sympatholytic
Adrenergic Antagonist (Sympatholytics)
ADRENERGIC MEDICATIONS (sympathomimetic drugs) BY:DR.ISRAA OMAR.
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
SYMPATHOMIMETIC DRUGS
SYMPATHOMIMETICS Classification: A- According to the source:
Adrenergic agonists Samuel Aguazim (MD).
ANTI-ADRENERGIC DRUGS
Sympathomimetics Ed Bilsky, Ph.D. Department of Pharmacology University of New England Phone , x2707
AUTONOMIC SYSTEMS AND DRUGS-2
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Adrenolytics. Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics Alpha & beta- adrenergic receptor blockers.
Chapter 33 Agents Affecting the Autonomic Nervous System.
Autonomic drugs: Adrenoceptor Agonists and Sympathomimetics
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Synthesis & Release of Neurotransmitters
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Sympatholytics Review 16 December :49 AM.
Adrenoceptor antagonist drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology) Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
BETA ADRENOCEPTOR BLOCKERS. OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL.
Adrenergic Antagonists (Sympatholytics)
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Classification of Adrenoreceptor Antagonists
Sympathomimetics Review 28 February :25 PM.
Autonomics Review 2 March :57 PM.
Sympathetic Nervous System.
 - Adrenoceptors blockers Prof. Hanan Hagar Pharmacology Unit College of Medicine.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
PHARMACOLOGY OFADRENERGICS
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
-ADRENOCEPTOR ANTAGONISTS
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
PHARMACOLOGY OFADRENERGICS
Adrenoceptor Antagonist Drugs
SYMPATHETIC NERVOUS SYSTEM
Sympatholytic & adrenergic blockers -receptor Antagonists
β – ADRENERGIC BLOCKERS
Sympathomimetic drugs
Beta-adrenergic blocking agents
جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical PharmacyKing Faisal University جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical.
Medicinal Chemistry II / lecture 4 3rd stage/ 2nd semester 28/3/2019
Adrenergic agonists and antagonists
- Adrenoceptors blockers
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonist
Sympatholytic Drugs Adrenergic neuron blockers Adrenergic receptor
Adrenergic Antagonists
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA

Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine- Norepinephrine –Isoproterenol- Clonidine 2. Indirect Acting –Tyramine, Amphetamine, Cocaine 3. Mixed Acting Agonists –Dopamine- Ephedrine –Amphetamine- Phenylpropanolamine –Metaraminol SYMPATHETIC DRUGS

Sympathetic Agonists SYMPATHOMIMETICS

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 β 1 and β 2 Sympathetic Agonists (Sympathomimetics) EPINEPHRINE NOREPINEPHRINE DOPAMINE IBOPAMINE AMPHETAMINE METHAMPHETAMINE EPHEDRINE PSEUDOEPHEDRINE DOBUTAMINE ISOPROTERENOL

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 β 1 and β 2 Sympathetic Agonists (Sympathomimetics) PHENYLEPHRINE METHOXAMINE MEPHENTERMINE METARAMINOL MITODRINE

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 β 1 and β 2 Sympathetic Agonists (Sympathomimetics) METHYLDOPA CLONIDINE GUANABENZ GUANFACINE

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 β 1 and β 2 Sympathetic Agonists (Sympathomimetics) NAPHAZOLINE TETRAHYDROZOLINE OXYMETAZOLINE XYLOMETAZOLINE

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 β 1 and β 2 Sympathetic Agonists (Sympathomimetics) METAPROTERENOL TERBUTALINE, ALBUTEROL RITODRINE ISOETHARINE, PILBUTEROL BITOLTEROL, FENOTEROL FORMOTEROL, SALMETEROL PROCATEROL

Special sympathomimetics: Special sympathomimetics:COCAINE –Local anesthetic –Inhibits uptake 1  Peripheral sympathomimetic action –CNS  inhibits reuptake of dopamine into neurons in the “pleasure centers” of the brain Sympathetic Agonists (Sympathomimetics)

Special sympathomimetics: Special sympathomimetics:TYRAMINE –Normal by-product of tyrosine metabolism –Fermented foods  cheese, red wine –Metabolized by MAO –Release of stored catecholamines  indirect sympathomimetic action Sympathetic Agonists (Sympathomimetics)

Sympathetic Antagonists SYMPATHOLYTICS

1. Adrenergic Neuron Blockers (ANB) -Guanethedine, Reserpine 2. Adrenergic Receptor Blockers (ARB)  Reversible – Prazosin, Phentolamine, Tolazoline, Labetalol, Ergot alkaloids  Irreversible – Phenoxybenzamine, Dibenamine Sympathetic Antagonists (Sympatholytics)

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 Β 1 and β 2 YOHIMBINE BUTOXAMINE LABETALOL CARVEDILOL

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 β 1 and β 2 α 1 and α 2 Sympathetic Antagonists (Sympatholytics) PRAZOSIN, TERAZOSIN DOXAZOSIN, TRIMAZOSIN INDORAMIN, URADIPIL KETANSERIN, ALFUZOSIN BUNAZOSIN, TAMSULOSIN

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 Β 1 and β 2 Sympathetic Antagonists (Sympatholytics) PHENOXYBENZAMINE PHENTOLAMINE ERGOT ALKALOIDS NEUROLEPTIC DRUGS

PHENOXYBENZAMINE irreversible noncompetetive blockade (14-48 hrs) inhibits NE reuptake Blocks H 1, Ach and serotonin receptors Blocks catecholamine-induced vasoconstriction Epinephrine- reversal Cl. Indication:pheochromocytoma male erectile dysfunction peripheral vascular diseases Adv. Eff: postural hypotension, tachycardia

PHENTOLAMINE Competetive antagonist (4 hrs) Competetive antagonist (4 hrs) Epinephrine- reversal Epinephrine- reversal reduce PVR reduce PVR Cardiac stimulation  baroreflex & ↑ NE release Cardiac stimulation  baroreflex & ↑ NE release Inhibits serotonin responses Inhibits serotonin responses Indic: Pheochromocytoma, male erectile dysfunction Indic: Pheochromocytoma, male erectile dysfunction Adv. Eff: severe tachycardia, arrhythmia, myocardial ischemia, GI stimulation Adv. Eff: severe tachycardia, arrhythmia, myocardial ischemia, GI stimulation

Beta-Adrenergic Blocking Agents BETA - BLOCKERS

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 Β 1 and β 2 Sympathetic Antagonists (Sympatholytics) METOPROLOL ATENOLOL ACEBUTOLOL BETAXOLOL CELIPROLOL ESMOLOL

α1α1α1α1 α2α2α2α2 α and β β1β1β1β1 β2β2β2β2 α 1 and α 2 Β 1 and β 2 Sympathetic Antagonists (Sympatholytics) PROPRANOLOL NADOLOL, TIMOLOL PINDOLOL, LEVOBUNOLOL CARTEOLOL, BISOPROLOL

Beta- blockers Pharmacokinetics: Pharmacokinetics: – oral: peak in 1-3 hrs – extensive first-pass metabolism – half- lives: 3 to 10 hrs * Esmolol – 8 – 10 min * Nadolol – 24 hrs

PHARMACODYNAMICS: PHARMACODYNAMICS: – CVS: (-) chronotropic, (-) inotropic effects – Respiratory: bronchoconstriction – Eye: reduce IOP – Metabolic & Endocrine:  inhibits lipolysis  partial inhibition of glycogenolysis  ↑ VLDL and ↓ HDL  ↓ HDL: LDL ratio – ISA; MSA Beta- blockers

Properties of Beta-receptor blocking agents: Partial Agonist Activity ( ISA) Local Anesthetic Activity (MSA) Lipid Solu- bility EliminationHalf-life Approxi- mate Bioavai- lability Selective β 1 blockers Acebutolol++Low 3-4 hrs 50 Atenolol--Low 6-9 hrs 40 Betaxolol-SlightLow hrs 90 Esmolol--Low 8-10 min 0 Celiprolol+- No data 4-5 hrs 70 Metoprolol-+Mod 3-4 hrs 50

ISA (Partial Agonist Activity ) MSA (Local Anesthetic Activity) Lipid Solu- bility Elimina-tionHalf-life Approxi- mate Bioavai- lability NonSelective β 1 Blockers Propranolol-+High hrs 30 Carteolol+-Low 6 hrs 85 Carvedilol-- No Data 6-8 hrs Labetalol++Mod 5 hrs 30 Nadolol--Low hrs 33 Pindolol++Mod 3-4 hrs 90 Timolol--Mod 4-50 hrs 50 Properties of Beta-receptor blocking agents:

CLINICAL INDICATIONS: CLINICAL INDICATIONS:  Hypertension  Cardiac arrhythmias  Angina  CHF: Metoprolol, Bisoprolol, Carvedilol  Glaucoma: Timolol, Betaxolol, Carteolol, Levobunolol, Metipranolol  Neurologic: Migraine, somatic mgt. of anxiety, alcohol withdrawal  Misc: reduce portal vein pressure in cirrhosis Beta- blockers

Clinical toxicities: Clinical toxicities: 1.Drug allergy – rare 2.CNS effects – sedation, sleep disturbances, depression, psychotic rxns 3.Worsening of preexisting asthma & airway obstruction 4.Depress myocardial contractility & excitability 5.Hypoglycemic episodes Beta- blockers

DRUG INTERACTION: DRUG INTERACTION: – Calcium- channel VERAPAMIL  Severe hypotension  Bradycardia  CHF  arrhythmia Beta- blockers

“A heartfelt apology can’t change the past, but it can brighten the future.”

QUIZ 1. Major neurotransmitter of the Sympathetic Nervous System Write A if Agonist or B if Antagonist: 2. Epinephrine7. Phentolamine 3. Labetalol8. Cocaine 4. Clonidine9. Phenylephrine 5. Prazosin10. Ephedrine 6. Terbutaline